Standard InChI: InChI=1S/C22H25N3O7S/c1-9-12(7-11-5-4-6-24-8-11)13-19(33-22(23-3)25-13)10(2)17(9)31-21-16(28)14(26)15(27)18(32-21)20(29)30/h4-6,8,14-16,18,21,26-28H,7H2,1-3H3,(H,23,25)(H,29,30)/t14-,15-,16+,18-,21+/m0/s1
1.Akita H, Suzuki H, Hirohashi T, Takikawa H, Sugiyama Y.. (2002) Transport activity of human MRP3 expressed in Sf9 cells: comparative studies with rat MRP3., 19 (1):[PMID:11837698][10.1023/a:1013699130991]
2.Hirohashi T, Suzuki H, Sugiyama Y.. (1999) Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3)., 274 (1):[PMID:10329726][10.1074/jbc.274.21.15181]
3.Niinuma K, Takenaka O, Horie T, Kobayashi K, Kato Y, Suzuki H, Sugiyama Y.. (1997) Kinetic analysis of the primary active transport of conjugated metabolites across the bile canalicular membrane: comparative study of S-(2,4-dinitrophenyl)-glutathione and 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole glucuronide., 282 (1):[PMID:9262353]
4.Niinuma K, Kato Y, Suzuki H, Tyson CA, Weizer V, Dabbs JE, Froehlich R, Green CE, Sugiyama Y.. (1999) Primary active transport of organic anions on bile canalicular membrane in humans., 276 (1):[PMID:10330006][10.1152/ajpgi.1999.276.5.g1153]
5.Suzuki M, Suzuki H, Sugimoto Y, Sugiyama Y.. (2003) ABCG2 transports sulfated conjugates of steroids and xenobiotics., 278 (1):[PMID:12682043][10.1074/jbc.m212399200]